QYOBO logo — QYOBO aims to contribute to a more transparent, efficient &...

QYOBO

QYOBO aims to contribute to a more transparent, efficient & robust supply of pharmaceutical & chemical raw materials.

Founded 2019 Germany Germany 22 employees Analytics, Big Data +1

General Information

Company Name QYOBO
Founded Year 2019
Location Germany Germany
Employees 22
Industries Analytics, Big Data, Information Technology
Social

BounceWatch is an independent company data service, not affiliated with QYOBO. To contact QYOBO, visit qyobo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does QYOBO compare?

A PDF of QYOBO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting QYOBO soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About QYOBO

QYOBO aims to contribute to a more transparent, efficient & robust supply of pharmaceutical & chemical raw materials. The vision of the company is to contribute to a more efficient, safer, and resilient supply with pharmaceuticals by continuously developing cutting-edge software and growing their platform into a holistic intelligence solution serving the entire industry. The QYOBO platform provides unique, actionable intelligence on the pharmaceutical market by combining 250+ databases in a single spot. It covers drug shortages, millions of pharmaceutical supply chains, 10,000+ pharmaceutical sites, compliance, pricing, and more, driving fast, educated decisions along the entire value chain. Founded in 2019, QYOBO prides itself on the quality of its software, its laser-sharp focus on improvement, and the collaborative environment created for anyone working at QYOBO. The company operates in the industries of Analytics, Big Data, and Information Technology. Currently, there is no public information available regarding the last investment and investors.

Business keywords: pharmaceutical market intelligence, supply chain risk management, big data analytics, drug shortages monitoring, API sales optimization, compliance monitoring, pharmaceutical procurement, manufacturing site intelligence, drug quality assurance, holistic intelligence solution

No funding data available for QYOBO yet.

QYOBO Alternatives & Competitors

View All Alternatives
QYOBO vs
Mtrix
Mtrix Brazil

Data Strategy. Business Insights.

179 employees
Analytics, Big Data
QYOBO vs

Win public contracts, with tender monitoring, analysis, and market intelligence based on AI

Grant
17 employees
AI, Analytics
QYOBO vs

End-to-end Supplier Relationship Management system

Venture round
70 employees
Big Data, Information Technology

FAQ About QYOBO

QYOBO aims to contribute to a more transparent, efficient & robust supply of pharmaceutical & chemical raw materials.
QYOBO was founded in 2019.
QYOBO is headquartered in Germany.
QYOBO operates in Analytics, Big Data and Information Technology. Its work centres on pharmaceutical market intelligence, supply chain risk management, big data analytics and drug shortages monitoring.
QYOBO has approximately 22 employees.
Top alternatives and competitors to QYOBO include Mtrix, Hermix - win public contracts w. AI, Kodiak Hub, Polecat, T4V. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QYOBO and Mtrix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for QYOBO, https://bouncewatch.com/company/qyobo, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes